A Concise Synthesis of Glycolipids Based on Aspartic Acid

Building Blocks by Velasco-Torrijos, Trinidad et al.
Molecules 2012, 17, 11346-11362; doi:10.3390/molecules171011346 
 
molecules 
ISSN 1420-3049 
www.mdpi.com/journal/molecules 
Article 
A Concise Synthesis of Glycolipids Based on Aspartic Acid 
Building Blocks 
Trinidad Velasco-Torrijos *, Lorna Abbey † and Roisin O’Flaherty † 
Department of Chemistry, National University of Ireland Maynooth, Co. Kildare, Ireland 
† These authors contributed equally to this work. 
* Author to whom correspondence should be addressed; E-Mail: trinidad.velascotorrijos@nuim.ie;  
Tel.: +353-01-708-3747; Fax: +353-01-708-3815. 
Received: 31 July 2012; in revised form: 15 September 2012 / Accepted: 21 September 2012 / 
Published: 25 September 2012 
 
Abstract: L-Aspartic acid building blocks bearing galactosyl moieties were used to 
synthesise glycolipid mimetics of variable hydrocarbon chain length. The glycolipids were 
readily prepared through amide bond formation using the TBTU/HOBt coupling 
methodology. It was observed that, under these conditions, activation of the α-carboxylic 
acid of the intermediates led to near complete racemisation of the chiral centre if the reaction 
was carried out in the presence of a base such as triethylamine. The enantiomerically pure 
glycolipids were obtained after careful consideration of the synthetic sequence and by 
performing the coupling reactions in the absence of base. 
Keywords: synthetic glycolipids; glycosylated amino acids; glycomimetics; aspartic acid; 
racemization 
 
1. Introduction 
Synthetic glycomimetics have been the subject of much research activity in the field of 
carbohydrate chemistry. The important role of carbohydrates in biological systems has prompted the 
development of different types of glycomimetics intended for diverse applications, such as therapeutic 
leads [1,2], novel materials [3], biosensors and diagnostic tools [4,5]. Glycolipid mimetics [6], in 
particular synthetic derivatives of biologically relevant ceramides (such as galactosyl ceramides, 
shown in Figure 1a), have attracted the attention of many carbohydrate chemists over recent years [7]. 
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Amino acids that allow for side chain functionalization with glycosyl moieties, such as serine and 
aspartic acid, have been popular choices as the starting point for the preparation of glycolipid 
analogues [8,9]. The carboxylic acid present on the aspartic acid side chain offers the possibility for 
attachment of mono or oligosaccharides, while both the amino and carboxylic acid groups at the  
α-carbon allow for further functionalization. Due to the biological relevance of N-linked glycosides, 
this type of building blocks has been used predominantly in the synthesis of glycopeptides and 
glycopeptoids and hence, numerous examples of such compounds can be found in the literature [10–13]. 
In this study we report our investigations towards the synthesis of galactosylated building blocks based 
on: (i) orthogonally protected; (ii) enantiomerically pure and (iii) commercially available L-aspartic 
acid derivatives, as we intend to expand their application to the preparation of glycolipid mimetics. 
These non-natural glycolipids may be bioactive as neuroprotective agents [14] and/or may be used in 
materials or formulation science [15]. The nature of the building blocks should allow for a modular 
approach which could lead to the facile preparation of a small collection of glycolipids of different 
fatty acids chain lengths, such as 1–4, shown in Figure 1b. This feature of the glycolipid structure 
affects strongly its physicochemical characteristics, as well as its potential biological activity [16]. 
Figure 1. (a) Structure of the naturally occurring glycolipid -galactosyl ceramide.  
(b) Structure of the galactosyl amines 5 [17,18] and 6 [19] and of the commercially 
available L-aspartic acid derivatives 7 and 8, used for the modular synthesis of glycolipid 
mimetics 1–4.  
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We have initially focused our attention on derivatives of decanoic acid (C-10), such as 1 and 3, and 
tetracosanoic acid (C-24), such as 2 and 4, as representative examples of medium and long fatty acid 
chain lengths. In glycolipids 1 and 2, the galactosyl moiety is connected to the aspartic acid by a 
flexible ethylene-type linker, while glycomimetics 3 and 4 resemble the native N-linked glycosides, as 
the acid conjugation occurs directly at the anomeric center. It is therefore expected that both sets of 
compounds would have different degrees of conformational freedom, which in turn may have an effect 
on their potential biological activities and physical properties. 
2. Results and Discussion 
Synthesis of the Glycolipids  
Both the galactosyl amines 5 [17,18] and 6 [19] used in the syntheses described herein are readily 
prepared from D-galactose pentacetate following procedures described in literature. Our initial 
approach to the glycolipid mimetics 1–4 involved a convergent synthesis (Scheme 1), whereby the  
N-Boc--benzyl ester protected L-aspartic acid 7 was coupled to tetradecylamine using standard 
TBTU/HOBt activation conditions in the presence of triethylamine. Subsequent removal of the N-Boc 
protecting group with TFA afforded the amine 9a, which was acylated with decanoic acid using the 
above mentioned TBTU/HOBt methodology. Hydrogenolysis of the side chain benzyl ester was 
carried out at 50 °C to enhance solubility and it afforded carboxylic acid 10a, which was then coupled 
to the primary amine of galactosyl derivative 6, to yield the acetyl protected glycolipid 11a. The  
1H-NMR spectrum of 11a showed distinct duplication of every expected signal in a 1:1 ratio. To rule 
out possible conformational exchange equilibrium, variable temperature 1H-NMR spectra of compound 
11a were recorded in d6-DMSO. No coalescence of the signals was observed at temperatures as high as 
80 °C, which confirmed that glycolipid 11a was, in fact, a mixture of diastereoisomers.  
Scheme 1. Synthesis of glycolipids 11a and 11b. 
O
AcO OAc
AcO
OAc
O N
H
H
N
HN
O
(  )8
O
(  )13
O
BnO OH
NHBoc
O
O
BnO
NH2
O
O H
N (  )13
HO
H
N
HN
O
(  )8
O
(  )13
O
7 9a (D/L mixture)
9b (L)
10a (D/L mixture)
10b (L)
11a (D/L mixture)
11b (L)
i
ii
iii
 
Reagents and conditions: (i) (1) TBTU, HOBt, C14H29NH2, NEt3, DMF, rt; (2) TFA, CH2Cl2, rt; 
81% over 2 steps (9a), 61% over 2 steps (9b)*; (ii) (1) TBTU, HOBt, C10H20O2, NEt3, DMF, rt;  
(2) H2, Pd/C, EtOAc, 50 °C; 80% over 2 steps (10a), 47% over 2 steps (10b); (iii) TBTU, HOBt, 6, 
NEt3, DMF, 50 °C; 60% (11a), 23% (11b). * The coupling reaction was carried out in the absence 
of NEt3 for 9b. 
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The unexpected racemisation of the chiral α-carbon of the L-aspartic acid derivative 7 takes place in 
the first step of the synthesis. Although the use of TBTU and HOBt as coupling reagents is a very 
standard procedure in peptide synthesis [20], the activation of the α-carboxylic acid under these 
conditions is likely to increase the acidity of the α-proton in 7 and it may be abstracted in the presence 
of a base such as triethylamine. This is further supported by the disappearance of the optical activity of 
compound 9a [[α]22D = 0 (c 1.55, CHCl3)], while if the same coupling reaction is carried out in the 
absence of triethylamine, a specific optical rotation value is obtained for the L-enantiomer, compound 
9b [[α]22D = +2.5 (c 1.55, CHCl3)]. The effects on reaction yields and racemisation of the products, 
caused by different bases and activating reagents commonly used in peptide couplings, have been 
extensively reviewed in the literature [21]. Most of the published procedures reporting amide bond 
formation of N-Boc aspartic acid 7 involve the use of carbodiimide-type coupling reagents [22], 
formation of activated esters, such as pentafluorophenyl derivatives [23], or mixed anhydrides [24]. 
However, no compromise of the optical purity of the resulting aspartate derivatives when using 
uronium-type reagents (such as TBTU or HBTU) has been explicitly reported so far, to the best of our 
knowledge [25,26]. The mixture of D and L diastereoisomers of glycolipid 11a could not be separated 
by flash column chromatography or by recrystallization. 
The same synthetic sequence as described above was carried out on the L-enantiomer 9b. Although 
this route allowed access to sufficient amounts of diastereomerically pure 11b, we decided to 
investigate a different synthetic sequence that may result in an overall higher yield for the 
enantiomerically pure glycolipids, as outlined in Scheme 2. In the first step of the reviewed scheme, 
the free amino galactosyl derivative 6 was coupled to the N-Boc aspartic acid benzyl ester 8, which 
bears the free carboxylic acid at the side chain, to give the orthogonally protected compound 12. The 
benzyl ester on 12 was removed by hydrogenolysis and the resulting carboxylic acid at the α-carbon 
was then carefully reacted again with the TBTU/HOBt system, followed by the addition of 
tetradecylamine. To avoid racemisation of the chiral carbon in this crucial step, this reaction was 
carried out in the absence of base. Under these conditions, enantiomerically pure 13 was successfully 
obtained, albeit in a moderate yield (51% over two steps). This building block was then reacted with 
TFA to cleave the N-Boc group and the corresponding amine was acylated with pre-activated decanoic 
acid (stirred with TBTU/HOBt prior to addition) to lead to the protected glycolipid 11b. Acylation of 
the amine derived from 13 by treatment with TBTU/HOBt and tetracosanoic acid instead gave the 
longer C-24 compound 14.The hydrolysis of the acetyl protecting groups on the galactosyl moiety of 
both derivatives 11a and 14 was initially attempted following standard procedures, such as the 
Zemplén deprotection or reaction with hydrazine [27]. However, these conditions proved to be rather 
harsh, resulting in amide bond hydrolysis and degradation of the glycolipids. Enzyme catalysed 
acetolyisis was also considered, using both immobilized enzymes (such as CALB, Candida antarctica 
lipase [28], immobilized as Novazym 435) and soluble lipases (such as CRL, Candida rugosa lipase) [29]. 
These and many other lipases have been reported to chemoselectively achieve total or partial 
deacetylation of protected glycosides. However, the success of enzyme-catalysed reactions is often 
highly dependent on substrate structure, and we found that, perhaps due to the steric bulk imposed by 
the hydrocarbon chains, not even partial deacetylation of any of the glycolipids could be achieved. The 
deprotection of 11b and 14 was most successfully carried out with mild base catalysis in a 
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heterogenous mixture of triethylamine and dichloromethane/methanol/water at 40 °C, to give the 
corresponding glycolipids 1 and 2. 
Scheme 2. Synthesis of O-glycolipids 1 and 2. 
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Reagents and conditions: (i) TBTU, HOBt, 6, NEt3, DMF, rt; 76%; (ii) (1) H2, Pd/C, EtOAc, rt;  
(2) TBTU, HOBt, C14H29NH2, DMF, rt; 51% over 2 steps; (iii) (1) TFA, CH2Cl2, 50 °C; (2) TBTU, 
HOBt, C10H20O2, DMF, rt; 47% over 2 steps (11b) or TBTU, HOBt, C23H47CO2H, DMF, rt; 14% 
over 2 steps (14); (iv) NEt3, CH2Cl2/MeOH/H2O, 40 °C; 83% (1), 38%, (2). 
Similar considerations regarding the preservation of the chirality of the L-aspartic acid asymmetric 
α-carbon were observed in the reviewed syntheses of the anomeric N-linked glycolipid analogues 3 
and 4 (Scheme 3). In this case, the synthesis starts again with the direct coupling of galactosyl amine 5 
with the N-Boc aspartic acid benzyl ester 8 to give building block 16 [30]. In order to avoid side 
reactions due to the increased acidity of the resulting anomeric amide, the reaction was carried out with 
TBTU/HOBt but in the absence of an added base. The next step involved the removal of the N-Boc 
group of 15 with TFA, and the corresponding amine was acylated with either pre-activated decanoic or 
tetracosanoic acid, to give the corresponding intermediates 16 and 17, respectively. It was expected 
that the presence of the long hydrocarbon chains would introduce steric hindrance and minimize the 
risk of intramolecular cyclization to yield aspartimide-type by-products when attempting the coupling 
of the α-carboxylic acid, as this is a well known side reaction in glycopeptides and glycoprotein 
synthesis [31,32]. Indeed, after 16 and 17 underwent hydrogenolysis, the corresponding carboxylic 
acids were subjected to reaction with tetradecylamine mediated by TBTU/HOBt to give the 
enantiomerically pure glycolipids 18 and 19, and no significant formation of cyclic products could be 
observed. Since Zemplén deacetylation may have involved too harsh conditions for the final 
deprotection of the glycolipids 11b and 14 described earlier, we used again the mildly basic hydrolysis 
method described above to access derivatives 3 and 4. It must be noted that the solubility of the C-24 
tetracosanoic acid derivatives, 2 and 4 is very poor (both in water and in most common solvents), when 
compared to that of the C-10 decanoic glycolipids 1 and 3. This is likely to hamper potential 
applications of the longer chain analogues. 
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Scheme 3. Synthesis of N-glycolipids 3 and 4. 
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Reagents and conditions: (i) TBTU, HOBt, 5, DMF, rt; 72%; (ii) (1) TFA, CH2Cl2, rt; (2) TBTU, 
HOBt, C10H20O2, DMF, rt; 63% over 2 steps (16) or TBTU, HOBt, C23H47CO2H, DMF, 50 °C; 46% 
over 2 steps (17); (iii) (1) H2, Pd/C, EtOAc, rt; (2) TBTU, HOBt, C14H29NH2, DMF, rt; 34% over  
2 steps (18) or (1) H2, Pd/C, EtOAc, rt; (2) TBTU, HOBt, C14H29NH2, DMF, rt; 25% over 2 steps 
(19); (iv) NEt3, CH2Cl2/MeOH/H2O, 40 °C; 21% (3), 79% (4). 
3. Experimental  
General Methods 
All chemicals purchased were reagent grade and used without further purification unless stated 
otherwise. Dichloromethane was freshly distilled over CaH2 prior use. Anhydrous dimethylformamide 
(DMF) was purchased from Sigma Aldrich. Molecular sieves (MS) used for glycosylation and 
coupling reactions were 8–12 mesh and were flame dried prior to use. Reactions were monitored with 
thin layer chromatography (TLC) on Merck Silica Gel F254 plates, using mixtures of hexane/ethyl 
acetate unless otherwise stated. Detection was effected either by visualisation in UV light and/or 
charring in a mixture of 5% sulphuric acid-EtOH or phosphomolybdic acid-EtOH. NMR spectra were 
obtained on a Bruker Avance 300 spectrometer. Proton and carbon signals were assigned with the aid 
of 2D-NMR experiments and DEPT experiments for novel compounds. The 2D-NMR experiments 
included COSY and HCCOSW, which is an HSQC type of experiment. Better resolution of the signals 
was observed when using the HCCOSW experiments than with conventional HSQC experiments. 
Chemicals shifts for 1H-NMR are reported in ppm relative to residual solvent proton. Flash 
chromatography was performed with Merck Silica Gel 60, using adjusted mixtures of hexane/ethyl 
acetate unless otherwise stated. Optical rotations were obtained using an AA-100 polarimeter. [α]25 
values are given in 10−1 cm2·g−1. The melting points were obtained using a Stuart Scientific SMP1 
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melting point apparatus and are uncorrected. High resolution mass spectrometry (HRMS) were 
performed on an Agilent-LC 1200 Series coupled to a 6210 Agilent Time-Of-Flight (TOF) mass 
spectrometer equipped with an electrospray source both positive and negative (ESI+/−) or in a 
MALDI-QTOF Premier MS SYSTEM, using an α-cyano-4-hydroxy cinnamic acid matrix. Infrared 
spectra were obtained as a film on NaCl plates in the region 4000–400 cm−1 on a Nicolet Impact 400D 
spectrophotometer. 
N4-[2-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-ethyl]-N2-tert-butoxycarbonyl-L-asparagine benzyl 
ester (12). HOBt (0.09 g, 0.68 mmol), followed by NEt3 (0.18 mL, 1.23 mmol), were added to a 
stirring solution of N-Boc-L-Asp-OBn 8 (0.2 g, 0.61 mmol) and TBTU (0.22 g, 0.6 mmol) dissolved in 
anhydrous DMF (10 mL), under N2 at rt. It was stirred for 30 min and 6 (0.29 g, 0.74 mmol) dissolved 
in anhydrous DMF (1.2 mL) was added dropwise. It was stirred for 18 h. The reaction mixture was 
concentrated under reduced pressure, diluted with ethyl acetate and washed succesively with HCl 0.1 N, 
aqueous sat. NaHCO3 solution, and brine. Flash chromotagraphy (hexane:ethyl acetate, 1:1) afforded 
12 as a white solid (0.33 g, 76%). [α]22D +6.9 (c 1.35, CH2Cl2,); IR (NaCl film): 3374.7, 2978.0, 
1750.7, 1665.8, 1499.3, 1368.8, 1224.3, 1167.9, 1124.3,1057.2 cm−1; 1H-NMR (300 MHz, CDCl3):  
7.34 (bs, 5 H, H-Ph), 6.01 (t, J = 5.1 Hz, 1 H, CH2CH2NHCO), 5.76 (d, J = 8.1 Hz, 1 H, NHCOC(CH3)3), 
5.39 (dd, J =0.6 Hz, J = 3.3 Hz, 1 H, H-4), 5.20–5.16 (m, 3 H, overlap of H-2, CH2Ph), 5.02 (dd,  
J = 3.3 Hz, J = 10.2 Hz, 1 H, H-3), 4.57–4.54 (m, 1 H, H-α), 4.44 (d, J = 7.8 Hz, 1 H, H-1), 4.18–4.13 
(m, 2 H, overlap of H-6, H-6'), 3.93–3.89 (m, 1 H, H-5), 3.86–3.80 (m, 1 H, 1 H of OCH2CH2NH), 
3.66–3.59 (m, 1 H, 1 H of OCH2CH2NH), 3.46–3.38 (m, 2 H, OCH2CH2NH), 2.91 (dd, J = 5.7 Hz,  
J = 17.4 Hz, 1 H, H-β), 2.71 (dd, J = 4.5 Hz, J = 15.9 Hz, 1 H, H-β'), 2.15 (s, 3 H, O(CO)CH3), 2.05 
(s, 6 H, O(CO)CH3 × 2), 1.99 (s, 3 H, O(CO)CH3), 1.42 (s, 9 H, COC(CH3)3); 13C-NMR (75 Hz, 
CDCl3):  171.38, 170.37, 169.76 (each CO), 155.55 (C-Ph), 128.51, 128.09 (CH-Ph), 101.42 (C-1), 
79.01 (COC(CH3)3), 70.89 (C-5), 70.68 (C-2), 68.91 (C-3), 67.25 (CH2Ph), 66.96 (C-4), 61.35 (C-6), 
50.47 (C-α), 39.18, 37.72 (each OCH2CH2NH), 37.12 (C-β), 28.29 (COC(CH3)3), 20.82, 20.57 
(overlap of O(CO)CH3); HRMS (MS-TOF): [M+H]+ calcd. for C32H44N2O15: 697.2181 found 697.2800. 
N4-[2-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-ethyl]-N2-tert-butoxycarbonyl-L-asparagine 
tetradecylamide (13). To a solution of 12 (0.120 g, 0.17 mmol) in ethyl acetate (6 mL), Pd/C 10% w/w 
(0.012 g, 10% w/w) was added. The resulting slurry was stirred under H2 gas for 4 h. The mixture was 
then filtered through a Celite cake and the filtrate was concentrated under vacuum to afford the 
corresponding carboxylic acid as an off-white solid, which was used without further purification 
(0.094 g, 90%). 1H-NMR (300 MHz, CDCl3):  6.53 (bs, 1 H, CH2CH2NHCO), 5.86 (d, J = 5.4 Hz, 1 H, 
NHCOC(CH3)3), 5.41 (d, J = 3.3 Hz, 1 H, H-4), 5.17 (dd, J = 7.8 Hz, J = 10.2 Hz, 1 H, H-2), 5.00 (dd, 
J = 3.3 Hz, J = 13.8 Hz, 1 H, H-3), 4.49 (d, J = 7.8 Hz, 1 H, H-1), 4.45–4.42 (m, 1 H, H-α), 4.20–4.11 
(m, 2 H, overlap of H-6, H-6'), 3.96–3.92 (m, 1 H, H-5) 3.90–3.85 (m,1 H, 1 H of OCH2CH2NH), 
3.75–3.68 (m, 1 H, 1 H of OCH2CH2NH), 3.54–3.39 (m, 2 H, OCH2CH2NH), 2.91 (d, J = 15.6 Hz, 1 H, 
H-β), 2.72 (dd, J = 8.49 Hz, J = 15.9 Hz, 1 H, H-β'), 2.17, 2.13, 2.05, 1.98 (each s, 3 H, O(CO)CH3), 
1.42 (s, 9 H, COC(CH3)3); HRMS (MS-TOF): [M+K]+ calcd. for C25H38N2O15: 645.1904 found 
645.1899. HOBt (0.034 g, 0.25 mmol) was added to a stirring solution of the carboxylic acid obtained 
as described above (0.140 g, 0.23 mmol), tetradecylamine (0.06 g, 0.28 mmol), and TBTU (0.081 g, 
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0.25 mmol) dissolved in anhydrous DMF, (12 mL) at rt. It was stirred for 18 h. The reaction mixture 
was concentrated in vacuo, diluted with ethyl acetate and washed with brine. Flash chromotagraphy 
(ethyl acetate) afforded 13 as a white solid (0.120 g, 56%). [α]22D = +8.8 (c 0.75, CH2Cl2,); IR (NaCl 
film): 3316.3, 3091.3 2919.9, 2851.3, 1748.0, 1687.1, 1646.1, 1548.9, 1524.1, 1467.4, 1434.6, 1369.2, 
1368.8, 1230.2, 1171.0, 1055.3 cm−1; 1H-NMR (300 MHz, CDCl3):  6.87 (bs, 1 H, CONHC14CH29), 
6.23 (t, J = 10.5 Hz, 1 H, CH2CH2NHCO), 6.14 (d, J = 8.1 Hz, 1 H, NHCOC(CH3)3), 5.38 (d, J = 2.7 Hz, 
1 H, H-4), 5.15 (dd, J = 7.8 Hz, J = 10.5 Hz, 1 H, H-2), 5.01 (dd, J = 3.3 Hz, J = 10.5 Hz, 1 H, H-3), 
4.49 (d, J = 7.8 Hz, 1 H, H-1), 4.40–4.39 (m, 1 H, H-α), 4.15–4.11 (m, 2 H, overlap of H-6, H-6'), 
3.94–3.87 (m, 1 H, H-5), 3.86–3.81 (m, 1 H, 1 H of OCH2CH2NH), 3.67–3.60 (m, 1 H, 1 H of 
OCH2CH2NH), 3.49–3.34 (m, 2 H, OCH2CH2NH), 3.22–3.15 (m, 2 H, NHCH2C13H27), 2.71 (dd,  
J = 4.2 Hz, J = 15.6 Hz, 1 H, H-β), 2.51 (dd, J = 6.6 Hz, J = 15.6 Hz, 1 H, H-β'), 2.14, 2.07, 2.02, 1.96 
(each s, 3 H, O(CO)CH3), 1.42 (m, 11 H, overlap of COC(CH3)3, NHCH2CH2C12H25), 1.23 (bs, 22 H, 
NHC2H4(CH2)11CH3), 0.87–0.83 (t, J = 6.6 Hz, 3 H, NHC13H26CH3); 13C-NMR (75 Hz, CDCl3):  171.17, 
170.88, 170.35, 170.18, 170.05, 169.85, 155.73 (CO), 101.31 (C-1), 80.14 (COC(CH3)3), 70.81, 70.72 
(C-5, C-3), 68.91. (C-2), 68.56 (NHCH2C13H27NH), 66.98 (C-4), 61.33 (C-6), 51.08 (C-α), 39.61, 
39.22 (each OCH2CH2NH), 37.54 (C-β), 31.9, 29.67, 29.63, 29.59, 29.53, 29.41, 29.33, 29.22 (each 
CH2), 28.30 (COC(CH3)3), 26.83, 22.67 (each CH2), 20.82–20.57 (overlap of O(CO)CH3), 14.93 
(NHC13H26CH3); HRMS (MS-TOF): [M+H]+ calcd. for C39 H67N3O14: 801.4623 found 801.4613. 
N4-[2-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-ethyl]-N2-decanoyl-L-asparagine tetradecylamide 
(11b). A solution of 13 (0.11 g, 0.13mmol) in anhydrous CH2Cl2, (6 mL) was cooled in an ice bath and 
TFA (0.15 mL, 1.37 mmol) was added. The reaction mixture was heated to 50 °C for 1.5 h. The 
organic solvent was removed in vacuo and the residue obtained was diluted with ethyl acetate and 
washed with aqueous sat. NaHCO3 solution and brine, dried (MgSO4) and concentrated to yield the 
corresponding deprotected amine as a brown oil, which was used without further purification (0.071 g, 
74%). 1H-NMR (300 MHz, CDCl3):  7.41 (bs, 1 H, CONHC14CH29), 6.42 (t, J = 5.1 Hz, 1 H, 
CH2CH2NHCO), 5.38 (d, J = 2.4 Hz, 1 H, H-4), 5.16 (dd, J = 7.8 Hz, J = 10.5 Hz, 1 H, H-2), 5.01 (dd, 
J = 3.3 Hz, J = 10.5 Hz, 1 H, H-3), 4.48 (d, J = 7.8 Hz, 1 H, H-1), 4.2–4.1 (m, 2 H, overlap of H-6, H-6'), 
3.94–3.89 (m, 1 H, H-5) 3.87–3.82 (m,1 H, 1 H of OCH2CH2NH), 3.67–3.64 (m, 2 H, overlap of 1 H 
of OCH2CH2NH, H-α), 3.42–3.46 (bm, 2 H, OCH2CH2NH), 3.20–3.22 (m, 2 H, NHCH2C13H27), 2.68 
(dd, J = 3.9 Hz, J = 15 Hz, 1 H, H-β), 2.46 (dd, J = 7.8 Hz, J = 15 Hz, 1 H, H-β'), 2.15, 2.07, 2.03, 
1.97 (each s, 3 H, O(CO)CH3), 1.50–1.43 (m, 2 H, NHCH2CH2C12H25), 1.23 (bs, 22 H, 
NHC2H4(CH2)11CH3), 0.87–0.83 (t, J = 6.6 Hz, 3 H, NHC13H26CH3); HRMS (MS-TOF): [M+H]+ 
calcd. for C34H59N3O12: 701.4099 found 701.4088. HOBt (0.041 g, 0.3 mmol) was added to a stirring 
solution of decanoic acid (0.048 g, 0.27 mmol) and TBTU (0.098 g, 0.3 mmol) dissolved in anhydrous 
DMF (6 mL), under N2 at rt. It was stirred for 10 min and the amine obtained from 13 as described 
above (0.06 g, 0.28 mmol) was dissolved in anhydrous DMF (8 mL) and added slowly. It was stirred 
for 18 h. The reaction mixture was concentrated in vacuo, diluted with ethyl acetate, washed with 
brine, dried (MgSO4) and concentrated . The residue obtained was purified by flash chromotagraphy 
(ethyl acetate) to afford 11b as a white solid (0.15 g, 63%). [α]22D = +5.8 (c 0.8, CH2Cl2,); IR (NaCl 
film): 3289.5, 3098.3, 2919.3, 2850.8, 1750.8, 168.1, 1646.5, 1542.4, 1467.4, 1370.4, 1225.5, 1174.9, 
1058.5 cm−1; 1H-NMR (300 MHz, CDCl3):  7.43 (d, J = 6.9 Hz, 1 H, NHCOC9H19), 7.08 (t, J = 5.4 Hz, 
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1 H, CONHC14CH29), 6.26 (t, J = 5.4 Hz, 1 H, CH2CH2NHCO), 5.40 (d, J = 2.4 Hz, 1 H, H-4), 5.18 
(dd, J = 7.8 Hz, J = 10.5 Hz, 1 H, H-2), 5.04 (dd, J = 3.3 Hz, J = 10.5 Hz, 1 H, H-3), 4.70–4.64 (m, 1 H, 
H-α), 4.54 (d, J = 7.8 Hz, 1 H, H-1), 4.22–4.11 (m, 2 H, overlap of H-6, H-6'), 3.97–3.94 (m, 1 H, H-5) 
3.92–3.85 (m, 1 H, 1 H of OCH2CH2NH), 3.69–3.64 (m, 1 H, 1 H of OCH2CH2NH), 3.57–3.39 (m,  
2 H, OCH2CH2NH), 3.22–3.16 (m, 2 H, NHCH2C13H27), 2.81 (dd, J = 3.3 Hz, J = 15.3 Hz, 1 H, H-β), 
2.46 (dd, J = 6.9, J = 15.6, 1 H, H-β'), 2.25–2.20 (t, J = 7.5 Hz, 2 H, COCH2C8H17), 2.16, 2.09,  
2.05, 1.9 (each s, 3 H, O(CO)CH3), 1.62–1.60 (m, 2 H, COCH2CH2C7H15), 1.46–1.45 (m, 2 H, 
NHCH2CH2C12H25), 1.26 (bs, 34 H, overlap of COC2H4(CH2)6CH3, NHC2H4(CH2)11CH3), 0.90–0.85 
(t, J = 6.6 Hz, 6 H, overlap of COC8H16CH3, NHC13H26CH3); 13C-NMR (75 Hz, CDCl3):  173.67, 
171.68, 170.61, 170.38, 170.20, 170.06, 169.90 (each CO), 101.33 (C-1), 70.81, 70.73 (C-5, C-3), 
68.97. (C-2), 68.51 (NHCH2C13H27), 66.98 (C-4), 61.30 (C-6), 49.72 (C-α), 39.67, 39.31 (each 
OCH2CH2NH), 36.98 (C-β), 36.62, 31.92, 29.70, 29.65, 29.56, 29.52, 29.36, 29.29, 28.31, 26.88, 
25.63, 22.62 (each CH2), 20.87–20.85 (overlap of O(CO)CH3), 14.12 (overlap of COC8H16CH3, 
NHC13H26CH3); HRMS (MS-TOF): [M+H]+ calcd. for C44H77N3O13: 855.5456 found 855.5492. 
N4-[2-O-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-ethyl]-N2-tetracosanoyl-L-asparagine 
tetradecylamide (14). HOBt (0.022 g, 0.16 mmol) was added to a stirring solution of tetracosanoic acid 
(0.056 g, 0.15 mmol) and TBTU (0.056 g, 0.16 mmol) dissolved in anhydrous DMF (6 mL), under N2 
at rt. It was stirred for 10 min and the amine obtained from 13 as described above (0.128 g, 0.18 mmol) 
was dissolved in anhydrous DMF (8 mL) and added slowly. It was stirred for 3 h. The reaction mixture 
was concentrated in vacuo, diluted with ethyl acetate, washed with brine, dried (MgSO4) and 
concentrated. The residue obtained was purified by flash chromotagraphy (ethyl acetate) to afford 14 
as a white solid, (0.030 g, 18%). [α]22D = +3.8 (c 0.83, CH2Cl2,); IR (NaCl film): 3423.0, 2918.4, 
2850.3, 1749.6, 1644.4,1543.1, 1465.6, 1369.9, 1223.4, 1058.3 cm−1; 1H-NMR (300 MHz, CDCl3):  
7.44 (d, J = 6.9 Hz, 1 H, NHCOC23H47), 7.09 (t, J = 4.8 Hz, 1 H, CONHC14CH29) 6.26 (bs, 1 H, 
CH2CH2NHCO), 5.40 (d, J = 3 Hz, 1 H, H-4), 5.17 (dd, J = 7.8 Hz , J = 10.5 Hz, 1 H, H-2), 5.04 (dd, 
J = 2.7 Hz, J = 10.2 Hz, 1 H, H-3), 4.70–4.64 (m, 1 H, H-α), 4.53 (d, J = 7.8 Hz, 1 H, H-1), 4.21–4.10 
(m, 2 H, overlap of H-6, H-6'), 3.97–3.92 (tm, 1 H, H-5) 3.90–3.85 (m,1 H, 1 H of OCH2CH2NH), 
3.71–3.64 (m, 1 H, 1 H of OCH2CH2NH), 3.54–3.44 (m, 2 H, OCH2CH2NH), 3.22–3.15 (m, 2 H, 
NHCH2C13H27), 2.77 (dd, J = 3.3 Hz, J = 15.3 Hz, 1 H, H-β), 2.45 (dd, J = 6.9 Hz, J = 15.6 Hz, 1 H, H-
β'), 2.25–2.20 (t, J = 7.5 Hz, 2 H, COCH2C22 H45), 2.16, 2.09, 2.04, 1.90 (each s, 3 H, O(CO)CH3), 
1.62–1.59 (m, 2 H, COCH2CH2C21H43), 1.46–1.45 (m, 2 H, NHCH2CH2C12H25), 1.25 (bs, 62 H, 
overlap of COC2H4(CH2)20CH3, NHC2H4(CH2)11CH3), 0.89–0.85 (t, J = 6.3 Hz, 6 H, overlap of 
COC22H44CH3, NHC13H26CH3); 13C-NMR (75 Hz, CDCl3):  173.57, 171.72, 170.58, 170.38, 170.20, 
170.07, 169.90 (each CO), 101.34 (C-1), 70.82, 70.73 (C-5, C-3), 68.98. (C-2), 68.54 (NHCH2C13H27), 
66.98 (C-4), 61.31 (C-6), 49.72 (C-α), 39.66, 39.24 (each OCH2CH2NH), 36.95 (C-β), 36.64 
(COCH2(CH2)20CH3), 31.92, 31.86, 29.66,29.56, 29.45, 29.36, 29.28, 26.89, 22.69, 22.66 (each CH2), 
20.88 (overlap of O(CO)CH3), 14.12 (overlap of COC22H44CH3, NHC13H26CH3); HRMS (MS-TOF): 
[M+H]+ calcd. for C58H105N3O13: 1052.772 found 1052.775. 
N4-[2-O-(β-D-Galactopyranosyl)-ethyl]-N2-decanoyl-L-asparagine tetradecylamide (1). Triethylamine 
(0.1 mL) was added to a stirring solution of 11b (0.120 g, 0.14 mmol) dissolved in 
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CH2Cl2/MeOH/H2O (3 mL/6 mL/3 mL) at 40 °C. It was stirred for 18 h. The reaction mixture was 
concentrated under reduced pressure to afford 1 as a white solid (0.080 g, 83%). [α]22D= −6.0 (c 0.33, 
C5H5N); 1H-NMR (300 MHz, d5-Pyr):  8.95 (d, J = 8.1 Hz, 1 H, NHCOC9H19), 8.87 (t, J = 5.4 Hz,  
1 H, CH2CH2NHCO), 8.55 (t, J = 5.7 Hz, 1 H, CONHC14CH29), 7.05, 6.79, 6.63, 6.39 (each bs, 1 H, 
OH), 5.55–5.53 (m, 1 H, H-α), 4.79 (d, J = 7.5 Hz, 1 H, H-1), 4.51–4.33 (m, 4 H, overlap of H-2, H-4, 
H-6, H-6'), 4.18–4.07 (m, 3 H, overlap of H-3, H-5, 1 H of OCH2CH2NH), 3.99–3.95 (m, 1 H, 1 H of 
OCH2CH2NH), 3.77–3.65 (m, 2 H, OCH2CH2NH), 3.22–3.16 (m, 2 H, NHCH2C13H27), 3.18 (td,  
J = 6.6 Hz, J = 1.2 Hz, 2 H, overlap of H-β, H-β'), 2.39–2.34 (t, J = 7.5 Hz, 2 H, COCH2C8H17),  
1.79–1.69 (m, 2 H, COCH2CH2C7H15), 1.60–1.50 (m, 2 H, NHCH2CH2C12H25), 1.20 (bs, 34 H, 
overlap of COC2H4(CH2)6CH3, NHC2H4(CH2)11CH3), 0.89–0.82 (m, 6 H, overlap of COC8H16CH3, 
NHC13H26CH3); 13C-NMR (75 Hz, d5-Pyr):  175.40, 173.98, 173.04 (each CO), 107.68 (C-1), 78.96, 
77.22, 74.52, 72.25 (C-2, C-4, C-3, C-5), 71.68 (NHCH2C13H27), 64.53 (C-6), 53.27 (C-α), 42.50, 
41.80 (each OCH2CH2NH), 40.71 (C-β), 38.49, 38.49, 34.09, 34.01,32.04, 31.95, 31.90, 31.68, 31.66, 
31.63, 31.58, 31.49, 29.22, 28.09 (each CH2), 18.63 (overlap of COC8H16CH3, NHC13H26CH3); HRMS 
(MS-TOF): [M+H]+ calcd. for C36H69N3O9: 688.5107 found 688.5099. 
N4-[2-O-(β-D-Galactopyranosyl)-ethyl]-N2-tetracosanoyl-L-asparagine tetradecylamide (2). Triethylamine 
(0.1 mL) was added to a stirring solution of 14 (0.016 g, 0.015mmol) dissolved in 
CH2Cl2/MeOH/H2O/THF (1 mL/2 mL/1 mL/2 mL) at 40 °C. The reaction mixture was stirred and its 
progress was followed by 1H-NMR spectra of aliquots. The reaction was deemed complete after 36 h. 
The reaction was concentrated under reduced pressure to afford 2 as a white solid (0.05 g, 38%).  
1H-NMR (300 MHz, d5-Pyr):  9.02–8.96 (m, 1 H, NHCOC23H47), 8.89–8.79 (m, 1 H, CH2CH2NHCO), 
8.54–8.52 (m, 1 H, CONHC14CH29), 5.54 (dd, J = 6.3, 12.9 Hz, 1 H, H-α), 4.80 (d, J = 7.8 Hz, 1 H,  
H-1), 4.52–4.36 (m, 4 H, overlap of H-2, H-4, H-6,H-6'), 4.18–4.10 (m, 3 H, overlap of H-3, H-5, 1 H 
of OCH2CH2NH), 3.99–3.95 (m, 1 H, 1 H of OCH2CH2NH), 3.77–3.65 (m, 2 H, OCH2CH2NH), 
3.48–3.38 (m, 2 H, NHCH2C13H27), 3.18 (m, 2 H, H-β, H-β'), 2.40–2.35 (m, 2 H, COCH2C22H45), 
1.79–1.69 (m, 2 H, COCH2CH2C21H43), 1.60–1.50 (m, 2 H, NHCH2CH2C12H25), 1.20 (bs, 62 H, 
overlap of COC2H4(CH2)20CH3, NHC2H4(CH2)11CH3), 0.89–0.82 (m, 6 H, overlap of COC22H44CH3, 
NHC13H26CH3); HRMS (MS-TOF): [M+H]+ calcd. for C50H97N3O9: 883.7225 found 883.7278. 
N4-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-N2-tert-butoxycarbonyl-L-asparagine benzyl ester 
(15) [30]. HOBt (1.30 g, 9.60 mmol) was added to a stirring solution of N-Boc-L-Asp-OBn 8 (1.55 g,  
4.80 mmol) and TBTU (3.08 g, 0.720 mmol) in anhydrous DMF (25 mL) under N2 at rt. It was stirred 
for 30 min and galactosyl amine 5 (2 g, 5.76 mmol) dissolved in anhydrous DMF (10 mL) was added 
dropwise to the solution. It was stirred for 18 h. The reaction mixture was concentrated in vacuo, 
diluted with ethyl acetate, washed with water, HCl 0.1 N and aqueous sat. NaHCO3 solution, dried 
(MgSO4) and concentrated. Flash chromatography (hexane/ethyl acetate 1:1) afforded 15 as a white solid 
(1.70 g, 72%). This was used without further purification. A small sample of 15 was recrystallised  
in CHCl3/hexane to give white crystals used for characterisation. [α]22D = +30 (c 1.2, CHCl3);  
m.p. = 148–150 °C; IR (NaCl film): 3348.7, 2965.2, 1749.6, 1499.7, 1369.0, 1221.7, 1054.5 771.3 
cm−1; 1H-NMR (300 MHz, CDCl3): δ 7.34–7.33 (m, 5 H, Ph-H), 6.38 (d, J = 9 Hz, NHCOC(CH3)3), 
5.70 (d, J = 9 Hz,1 H, NHCOCH2), 5.43 (d, J = 3 Hz, 1 H, H-4), 5.21–5.04 (m, 5 H, overlap of CH2Ph, 
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H-1, H-2, H-3), 4.58 (t, J = 6 Hz, 1 H, H-α), 4.15–3.97 (m, 3 H, overlap of H-5, H-6, H-6'), 2.95–2.84 
(m, 1 H, H-β'), 2.71 (dd, J = 3 Hz, J = 15 Hz, 1 H, H-β), 2.13 , 2.03,1.99, 1.98 (each s, 3 H, 
O(CO)CH3), 1.41 (9 H, O(CO)CH3)3); 13C-NMR (75 MHz, CDCl3): δ 171.53, 171.12, 170.54, 170.33, 
169.95, 169.74 (each CO), 135.33 (C-Ph), 128.50, 128.26, 127.88 (CH-Ph), 80.10 (C(CH3)3), 78.44 
(C-1), 72.40 (C-5), 70.67 (C-3), 68.17 (C-2), 67.29 (CH2Ph), 67.06 (C-4), 61.08 (C-6), 50.09 (C-α), 
37.85 (C-β), 28.25 (C(CH3)3), 20.66, 20.59, 20.57, 20.52 (each O(CO)CH3); HRMS (MS-TOF): 
[M+H]+ calcd. for C30H41N2O14: 653.2552 found 653.2541. 
N4-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-N2-decanoyl-L-asparagine benzyl ester (16). TFA 
(1.34 mL, 17.93 mmol) in anhydrous CH2Cl2 (1.34 mL) was added dropwise to a solution of 15 (1.17 g, 
1.79 mmol) in anhydrous CH2Cl2 (10 mL). It was stirred for 6 h. The reaction mixture was 
concentrated in the rotary evaporator and the residue was dissolved in CH2Cl2 and washed with 
aqueous sat. NaHCO3 solution, brine and water. The organic phase was dried (MgSO4) and 
concentrated in vacuo to yield the corresponding amine as a white foam (0.73 g, 74%). The compound 
was used without further purification. 1H-NMR (300 MHz, CDCl3): δ 8.10 (d, J = 9.3 Hz, 1 H, 
NHCOCH2), 7.51–7.31 (m, 5 H, Ph-H), 5.40 (d, J = 1.4 Hz, 1 H, H-4), 5.22 (t, J = 9.3 Hz, 1 H, H-1), 
5.12–5.07 (m, 4 H, overlap of CH2Ph, H-2, H-3), 4.11–3.97 (m, 3 H, overlap of H-5, H-6, H-6'), 3.67 
(bs, 1 H, H-α), 2.67–2.63 (m, 1 H, H-β), 2.39 (dd, J = 9.6 Hz, J = 5.3 Hz, 1 H, H-β'), 2.10, 2.00, 1.99, 
1.95 (each s, 3 H, O(CO)CH3); HRMS (MS-TOF): [M+Na]+ calcd. for C25H32O12N2Na: 553.2028 
found 553.2024. TBTU (56 mg, 0.18 mmol) and HOBt (24 mg, 0.18 mmol) were added to a solution 
of decanoic acid (27 mg, 0.16 mmol) in anhydrous DMF (2 mL) under N2 at rt. It was stirred for 20 min 
and the free amine obtained from 15 as described above (88 mg, 0.16 mmol) in anhydrous DMF  
(1 mL) was added dropwise to the solution. It was stirred for 18 h. The reaction mixture was 
concentrated in vacuo, diluted with ethyl acetate, washed with water and brine, dried (MgSO4) and 
concentrated. The residue obtained was purified by flash chromotagraphy (hexane/ethyl acetate 1:1) to 
yield 16 as a colourless oil (94 mg, 85%). [α]22D = +27.2 (c 1.76, CHCl3); IR (NaCl film): 3330.9, 
2926.4, 1751.0, 1674.3, 1530.8, 1370.1, 1222.5, 1179.4, 1052.8, 698.5 cm−1; 1H-NMR (300 MHz, 
CDCl3): δ 7.33–7.31 (m, 5 H, Ph-H), 6.73 (d, J = 8.3 Hz, 1 H, NHCOC9H19), 6.50 (d, J = 8.7 Hz, 1 H, 
NHCOCH2), 5.43 (d, J = 2.0 Hz, 1 H, H-4), 5.20–5.04 (m, 5 H, overlap of H-1, H-2, H-3, CH2Ph), 
4.93–4.87 (m, 1 H, H-α), 4.15–3.97 (m, 3 H, overlap of H-5, H-6, H-6'), 2.90 (dd, J = 4.1 Hz, J = 16.5 Hz, 
1 H, H-β), 2.70 (dd, J = 4.4 Hz, J = 16.4 Hz, 1 H, H-β'), 2.22–2.17 (t, J = 7.3 Hz, 2 H, COCH2C8H17), 
2.13, 2.03, 1.99, 1.98 (each s, 3 H, O(CO)CH3), 1.61–1.56 (m, 2 H, COCH2CH2C7H15), 1.24 (bs, 12 H, 
COC2H4(CH2)6CH3), 0.88–0.84 (t, J = 7.0 Hz, 3 H, COC8H16CH3); 13C-NMR (75 MHz, CDCl3): δ 
173.06, 171.49, 170.90, 170.82, 170.28, 169.95, 169.76 (each CO), 135.23, (Ph-C), 128.53, 128.33, 
127.92 (Ph-CH), 78.44 (C-1), 72.37 (C-5), 70.66 (C-3), 68.11 (C-2), 67.36 (CH2Ph), 67.00 (C-4), 
61.00 (C-6), 48.42 (C-α), 37.43 (C-β), 36.49, 31.81, 29.36, 29.27, 29.22, 29.18, 25.49, 22.62 (each 
CH2), 20.62, 20.55, 20.53, 20.49 (each O(CO)CH3), 14.06 (COC8H16CH3); HRMS (MS-TOF,): 
[M+Na]+ calcd. for C35H50O13N2Na: 707.3386 found 707.3376. 
N4-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-N2-tetracosanoyl-L-asparagine benzyl ester (17). TBTU 
(59 mg, 0.183 mmol) and HOBt (25 mg, 0.183 mmol) were added to tetracosanoic acid (62 mg,  
0.167 mmol) in anhydrous DMF (3 mL) containing 4 Å MS under N2 at rt. It was stirred for 30 min 
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and the free amine obtained from 15 as described above (88 mg, 0.16 mmol) in anhydrous DMF  
(2 mL) was added dropwise to the solution. It was stirred for 2 h at 50 °C. The reaction mixture was 
concentrated in vacuo, diluted with ethyl acetate, washed with water and brine, dried (MgSO4) and 
concentrated under reduced pressure. The residue obtained was purified by flash chromotagraphy 
(hexane/ethyl acetate 1:1) to yield 17 as a white solid (93 mg, 62%). [α]25D = +18.9 (c 0.95, ethyl 
acetate); IR (NaCl film): 2918.7, 2850.5, 1750.5, 1371.1, 1231.8, 1054.9, 913.2, 743.7 cm−1; 1H-NMR 
(300 MHz, CDCl3): δ 7.33–7.31 (m, 5 H, H-Ph), 6.73 (d, J = 8.3 Hz, 1 H, NHCOC23H47), 6.48 (d,  
J = 8.6 Hz, 1 H, NHCOCH2), 5.43 (d, J = 2.0 Hz, 1 H, H-4), 5.20–5.07 (m, 5 H, overlap of H-1, H-2, 
H-3, CH2Ph), 4.93–4.88 (m, 1 H, H-α), 4.15–3.97 (m, 3 H, overlap of H-5, H-6, H-6'), 2.91 (dd, J = 3.9 Hz, 
J = 16.4 Hz, 1 H, H-β'), 2.71 (dd, J = 4.4 Hz, J = 16.4 Hz, 1 H, H-β'), 2.22–2.17 (t, J = 7.5 Hz, 2 H, 
COCH2C22H45), 2.13, 2.04, 2.03, 1.99 (each s, 3 H, O(CO)CH3), 1.61–1.56 (m, 2 H, COCH2CH2C21H43), 
1.25 (bs, 40 H, COC2H4(CH2)20CH3, 0.89–0.85 (t, J = 7.0 Hz, 3 H, COC22H44CH3); 13C-NMR (75 Hz, 
CDCl3): δ 173.09, 171.53, 170.91, 170.82, 170.29, 169.97, 169.77 (each CO), 135.23, 128.54, 128.35 
(CH-Ph), 127.93 (C-Ph), 78.46 (C-1), 72.38 (C-5), 70.66 (C-3), 68.12 (C-2), 67.39 (CH2Ph), 67.00  
(C-4), 61.00 (C-6), 48.43 (C-α), 37.45 (C-β), 36.52, 31.89, 29.67, 29.62, 29.45, 29.33, 29.31, 29.21, 
25.51, 22.66 (each CH2), 20.64, 20.57, 20.55, 20.51 (each O(CO)CH3), 14.09 (COC22H44CH3); HRMS 
(MS-TOF): [M+H]+ calcd. for C49 H79O13N2: 904.5610 found 904.5632. 
N4-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-N2-decanoyl-L-asparagine tetradecylamide (18). H2 gas 
was bubbled through a suspension of 16 (56 mg, 0.079 mmol) in ethyl acetate (10 mL) and Pd/C 10% 
w/w (6 mg, 10% w/w) was added. It was left to stir for 3 h and then the reaction mixture was filtered 
through Celite washing with ethyl acetate and concentrated in vacuo, to yield the corresponding 
carboxylic acid as a colourless oil, which was used without further purification (30 mg, 61%).  
1H-NMR (300 MHz, CDCl3): δ 7.24 (d, J = 6.8 Hz, 1 H, NHCOC9H19), 6.57 (d, J = 9.4 Hz, 1 H, 
NHCOCH2), 5.53 (d, J = 1.7 Hz, 1 H, H-4), 5.35 (m, 1 H, H-1), 5.16–5.10 (m, 2 H, overlap of H-2,  
H-3), 4.74–4.71 (m, 1 H, H-α), 4.25–4.00 (m, 3 H, overlap of H-5, H-6, H-6'), 2.87 (dd, J = 3.6 Hz,  
J = 16.4 Hz, 1 H, H-β), 2.77 (dd, J = 4.8 Hz, J = 16.5 Hz, 1 H, H-β'), 2.32–2.27 (t, J = 8.0 Hz, 2 H, 
COCH2C8H17), 2.15 (s, 3 H, O(CO)CH3), 2.05 (s, 6 H, O(CO)CH3 × 2), 2.00 (s, 3 H, O(CO)CH3), 
1.65–1.60 (m, 2 H, COCH2CH2C7H15), 1.25 (bs, 12 H, COC2H4(CH2)6CH3), 0.89–0.85 (t, J = 6.9 Hz,  
3 H, COC8H16CH3); HRMS (MS-TOF): [M+H]+ calcd. for C28H45O13N2: 617.2916 found 617.2900. 
TBTU (14 mg, 0.045 mmol) and HOBt (6 mg, 0.045 mmol) were added to a solution of the carboxylic 
acid obtained from 16 as described above (25 mg, 0.041 mmol) in anhydrous DMF (3 mL) under N2 at rt. 
It was stirred for 30 min and tetradecylamine (9 mg, 0.041 mmol) was added to the solution and it was 
stirred for 3 h. The reaction mixture was concentrated in vacuo, diluted with ethyl acetate, washed with 
brine and water, dried (MgSO4) and concentrated. The residue obtained was purified by flash 
chromotagraphy (hexane/ethyl acetate 1:1) to yield 18 as a white solid (18 mg, 55%). [α]25D = +20.0  
(c 0.75, CH2Cl2); IR (NaCl film): 3286.1, 2924.1, 2853.8, 1751.2, 1642.6, 1546.1, 1466.7, 1371.0, 
1227.6, 1054.9 cm−1; 1H-NMR (300 MHz, CDCl3): δ 7.58 (d, J = 7.6 Hz, 1 H, NHCOC9H19), 6.79–6.74 
(m, 2 H, overlap of NHCOCH2, CONHC14CH29), 5.44 (d, J = 1.6 Hz, 1 H, H-4), 5.23–5.10 (m, 3 H, 
overlap of H-1, H-2, H-3), 4.71–4.67 (m, 1 H, H-α), 4.16–3.99 (m, 3 H, overlap of H-5, H-6, H-6'), 
3.18–3.11 (m, 2 H, NHCH2C13H27), 2.69 (dd, J = 3.4 Hz, J = 15.6 Hz, 1 H, H-β), 2.44 (dd, J = 5.6 Hz, 
J = 15.5 Hz, 1 H, H-β'), 2.25–2.21 (m, 2 H, COCH2C8H17), 2.17, 2.14, 2.04, 2.00 (each s, 3 H, 
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O(CO)CH3), 1.65 (bs, 2 H, COCH2CH2C7H15), 1.46–1.42 (m, 2 H, NHCH2CH2C12H25), 1.25 (bs, 34 H, 
overlap of COC2H4(CH2)6CH3, NHC2H4(CH2)11CH3), 0.90–0.85 (t, J = 6.9 Hz, 6 H, overlap of 
COC8H16CH3, NHC13H26CH3); 13C-NMR (75 MHz, CDCl3): δ 173.77, 173.03, 172.25, 170.35, 170.30, 
170.01, 169.79 (each CO), 78.49 (C-1), 72.31 (C-5), 70.73 (C-3), 67.84 (C-2), 67.05 (C-4), 61.06  
(C-6), 49.75 (C-α), 39.59 (NHCH2C13H27), 36.60 (C-β), 36.21, 31.91, 31.84, 29.68, 29.65, 29.61, 
29.55, 29.44, 29.35, 29.31, 29.26, 26.89, 25.63, 22.68, 22.65 (each CH2), 20.89, 20.67, 20.59, 20.54, 
(each O(CO)CH3), 14.11 (overlap of COC8H16CH3, NHC13H26CH3); HRMS (MS-TOF): [M+Na]+ 
calcd. for C42 H73O12N3Na: 834.5086 found 834.5079. 
N4-(2,3,4,6-Tetra-O-acetyl-β-D-galactopyranosyl)-N2-tetracosanoyl-L-asparagine tetradecylamide (19). 
H2 gas was bubbled through a suspension of 17 (67 mg, 0.074 mmol) in ethyl acetate (5 mL) and Pd/C 
10% w/w (7 mg, 10% w/w) was added. It was left to stir for 18 h and then the reaction mixture was 
filtered through Celite, washed with ethyl acetate and concentrated in vacuo to yield the corresponding 
carboxylic acid as a white solid, which was used without further purification (60 mg, 55%). 1H-NMR 
(300 MHz, CDCl3): δ 7.20 (d, J = 7.0 Hz, 1 H, NHCOC23H47), 6.62 (d, J = 9.2 Hz, 1 H, NHCOCH2), 
5.51 (d, J = 1.2 Hz, 1 H, H-4), 5.34–5.28 (m, 1 H, H-1), 5.12–5.10 (m, 2 H, overlap of H-2, H-3),  
4.76–4.71 (m, 1 H, H-α), 4.22–4.02 (m, 3 H, overlap of H-5, H-6, H-6'), 2.96–2.84 (m, 1 H, H-β), 2.75 
(dd, J = 5.0 Hz, J = 16.5 Hz, 1 H, H-β'), 2.37–2.26 (m, 2 H, COCH2C22H45), 2.15, 2.06, 2.05, 2.00 
(each s, 3 H, O(CO)CH3), 1.67–1.58 (m, 2 H, COCH2CH2C21H43), 1.25 (bs, 40 H, COC2H4(CH2)20CH3), 
0.90–0.85 (t, J = 6.9 Hz, 3 H, COC22H44CH3); HRMS (MS-TOF): [M+H]+ calcd. for C42H73O13N2: 
813.5107 found 813.5106. TBTU (12 mg, 0.037 mmol) and HOBt (5 mg, 0.037 mmol) were added to 
a solution of the carboxylic acid obtained from 17 as described above (27 mg, 0.033 mmol) in 
anhydrous DMF (3 mL), containing 4 Å MS, under N2 and at rt. It was stirred for 20 min and 
tetradecylamine (7 mg, 0.033 mmol) was added to the solution. It was stirred for 18 h. The reaction 
mixture was concentrated in vacuo, diluted with ethyl acetate, washed with brine and water, dried 
(MgSO4) and concentrated under reduced pressure. Flash chromatography (hexane/ethyl acetate 1:1) 
afforded 19 as a white solid (15 mg, 45%). [α]25D = +09.2 (c 0.65, CH2Cl2); IR (NaCl film): 3426.0, 
2918.5, 2850.5, 1750.7, 1641.8, 1228.5 cm−1; 1H-NMR (300 MHz, CDCl3): δ 7.58 (d, J = 7.8 Hz, 1 H, 
NHCOC23H47), 6.78–6.73 (m, 2 H, overlap of NHCOCH2, CONHC14CH29), 5.45 (d, J = 1.8 Hz, 1 H, 
H-4), 5.26–5.10 (m, 3 H, overlap of H-1, H-2, H-3), 4.71–4.66 (m, 1 H, H-α), 4.17–3.98 (m, 3 H, overlap 
of H-5, H-6, H-6'), 3.26–3.11 (m, 2 H, NHCH2C13H27), 2.69 (dd, J = 3.5 Hz, J = 15.7 Hz, 1 H, H-β), 2.44 
(dd, J = 5.6 Hz, J = 15.7 Hz, 1 H, H-β'), 2.24–2.21 (m, 2 H, COCH2C22H45), 2.17, 2.14, 2.04, 2.00 (each 
s, 3 H, O(CO)CH3), 1.66 (bs, 2 H, COCH2CH2C21H43), 1.46–1.42 (m, 2 H, NHCH2CH2C12H25), 1.25 
(bs, 62 H, overlap of COC2H4(CH2)20CH3, NHC2H4(CH2)11CH3), 0.90–0.85 (t, J = 6.9 Hz, 6 H, 
overlap of COC22H44CH3, NHC13H26CH3); 13C-NMR (75 MHz, CDCl3): δ 173.77, 173.03, 172.24, 
170.35, 170.29, 170.00, 169.78 (each CO), 78.47 (C-1), 72.30 (C-5), 70.72 (C-3), 67.83 (C-2), 67.04 
(C-4), 61.04 (C-6), 49.73 (C-α), 39.57 (NHCH2C13H27), 36.59 (C-β), 36.18,31.90, 29.68, 29.33, 26.87, 
25.62, 22.66, (each CH2), 20.87, 20.64, 20.57, 20.51, (each O(CO)CH3), 14.09 (overlap of 
COC22H44CH3, NHC13H26CH3); HRMS (MS-TOF): [M+H]+ calcd. for C56H102O12N3: 1008.7458 
found 1008.7429. 
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N4-β-D-Galactopyranosyl-N2-decanoyl-L-asparagine tetradecylamide (3). Triethylamine (0.05 mL) 
was added to a stirring solution of 18 (0.043 g, 0.053 mmol) dissolved in CH2Cl2/MeOH/H2O  
(1 mL/2 mL/1 mL) at 40 °C. It was stirred for 18 h. The precipitate formed was filtered through a 
vacuum to afford 3 as white crystals (7 mg, 21%). [α]22D = −6.7 (c 0.6, C5H5N); 1H-NMR (300 MHz, 
d5-Pyr):  10.14 (d, J = 9.1 Hz, 1 H, NHCOCH2), 8.94 (d, J = 7.9 Hz, 1 H, NHCOC9H19), 8.53–8.48 (t, 
J = 5.7 Hz, 1 H, CONHC14CH29), 5.91–5.78 (t, J = 9.2 Hz, 1 H, H-1), 5.45 (dd, J = 6.8, 14.3 Hz, 1 H, 
H-α), 4.58 (d, J = 2.9 Hz, 1 H, H-4), 4.56–4.49 (t, J = 9.2 Hz, 1 H, H-2), 4.38 (dd, J = 2.1 Hz, J = 6.1 Hz, 
2 H, H-6, H-6'), 4.17 (dd, J = 3.0 Hz, J = 9.0 Hz, 1 H, H-3), 4.13–4.09 (t, J = 5.8 Hz, 1 H, H-5),  
3.45–3.34 (m, 2 H, NHCH2C13H27), 3.27 (d, J = 6.5 Hz, 2 H, H-β, H-β'), 2.36–2.31 (t, J = 7.5 Hz, 2 H, 
COCH2C8H17), 1.75–1.70 (m, 2 H, COCH2CH2C7H15), 1.58–1.50 (m, 2 H, NHCH2CH2C12H25), 1.24 
(bs, 34 H, overlap of COC2H4(CH2)6CH3, NHC2H4(CH2)11CH3), 0.88–0.81 (m, 6 H, overlap of 
COC8H16CH3, NHC13H26CH3); 13C NMR (d5-Pyr, 75 Hz): δ 173.41, 171.98, 171.83, (each CO), 81.74 
(C-1), 78.35 (C-5), 76.19 (C-3), 71.90 (C-2), 70.42 (C-4), 62.37 (C-6), 51.13 (C-α), 39.89 
(NHCH2C13H27), 39.05 (C-β), 36.46, 32.08, 32.00, 29.94, 29.88, 29.67. 29.64, 29.61, 29.57, 29.48, 
27.25, 26.02, 22.89, 22.85 (each CH2), 14.22 (overlap of COC8H16CH3, NHC13H26CH3); HRMS (MS-
TOF): [M+Na]+ calcd for C34H65O8N3Na: calcd: 666.4664 found 666.4689. 
N4-β-D-Galactopyranosyl-N2-tetracosanoyl-L-asparagine tetradecylamide (4). Triethylamine (0.05 mL) 
was added to a stirring solution of 19 (0.035 g, 0.035mmol) dissolved in CH2Cl2/MeOH/H2O  
(1 mL/2 mL/1 mL) at 40 °C. It was stirred for 18 h. The precipitate formed was filtered through a 
vacuum to afford 4 as a white solid (23 mg, 79%). 1H-NMR (300 MHz, d5-Pyr):  10.20–10.14 (m,  
1 H, NHCOCH2), 9.02–8.90 (m, 1 H, NHCOC23H47), 8.50 (t, J = 5.5 Hz, 1 H, CONHC14CH29), 5.90 
(dd, J = 8.9 Hz, J = 17.9 Hz, 1 H, H-1), 5.65–5.61 (m, 1 H, H-α), 4.73 (d, J = 6.1 Hz, 1 H, H-4), 4.60 
(d, J = 2.9 Hz, 1 H, H-2), 4.56–4.36 (m, 3 H, overlap of H-6, H-6', H-3), 4.20–4.13 (m, 1 H, H-5), 
3.49–3.38 (m, 2 H, NHCH2C13H27), 3.29–3.21 (m, 2 H, H-β, H-β'), 2.35 (t, J = 7.5 Hz, 2 H, 
COCH2C22H45), 1.77–1.73 (m, 2 H, COCH2CH2C21H43), 1.59–1.54 (m, 2 H, NHCH2CH2C12H25), 1.26 
(bs,62 H, overlap of COC2H4(CH2)20CH3, NHC2H4(CH2)11CH3), 0.89–0.85 (m, 6 H, overlap of 
COC8H16CH3, NHC13H26CH3); HRMS (MALDI MS-QTOF): [M+Na]+ calcd for C48H93O8N3Na: 
calcd: 862.6860 found 862.6841. 
4. Conclusions  
In summary, we present a short and convenient route to access glycolipid mimetics from suitably 
protected and commercially available L-aspartic acid building blocks and easily synthesized galactosyl 
amines. A small collection of compounds of diverse structural characteristics has been prepared. The 
design of suitably assembled building blocks and careful consideration of the synthetic sequence, to 
avoid undesired side reactions, will allow for the next generation of glycolipid mimetics bearing 
different mono or oligosaccharides, as well as fatty acid derivatives of different chain lengths and 
saturation patterns. 
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